<!DOCTYPE html>
<html lang="zh-CN">
<head>
  <meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=2">
<meta name="theme-color" content="#222">
<meta name="generator" content="Hexo 6.3.0">
<meta name="baidu-site-verification" content="codeva-q4zg3o0c1B" />
  <link rel="apple-touch-icon" sizes="180x180" href="/images/favicon.ico">
  <link rel="icon" type="image/png" sizes="32x32" href="/images/favicon.ico">
  <link rel="icon" type="image/png" sizes="16x16" href="/images/favicon.ico">
  <link rel="mask-icon" href="/images/favicon.ico" color="#222">

<link rel="stylesheet" href="/css/main.css">


<link rel="stylesheet" href="/lib/font-awesome/css/all.min.css">
<link href="https://fonts.loli.net/css?family=Noto+Serif+SC|Roboto&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="//cdn.jsdelivr.net/gh/fancyapps/fancybox@3/dist/jquery.fancybox.min.css">
  <link rel="stylesheet" href="//cdn.jsdelivr.net/npm/pace-js@1/themes/blue/pace-theme-minimal.css">
  <script src="//cdn.jsdelivr.net/npm/pace-js@1/pace.min.js"></script>

<script id="hexo-configurations">
    var NexT = window.NexT || {};
    var CONFIG = {"hostname":"www.zhuangqingyuan.site","root":"/","scheme":"Mist","version":"7.8.0","exturl":false,"sidebar":{"position":"left","display":"post","padding":18,"offset":12,"onmobile":false},"copycode":{"enable":true,"show_result":false,"style":"mac"},"back2top":{"enable":true,"sidebar":true,"scrollpercent":true},"bookmark":{"enable":true,"color":"#222","save":"auto"},"fancybox":true,"mediumzoom":false,"lazyload":false,"pangu":false,"comments":{"style":"tabs","active":"valine","storage":true,"lazyload":false,"nav":null,"activeClass":"valine"},"algolia":{"hits":{"per_page":10},"labels":{"input_placeholder":"Search for Posts","hits_empty":"We didn't find any results for the search: ${query}","hits_stats":"${hits} results found in ${time} ms"}},"localsearch":{"enable":true,"trigger":"auto","top_n_per_article":1,"unescape":false,"preload":false},"motion":{"enable":true,"async":false,"transition":{"post_block":"fadeIn","post_header":"slideDownIn","post_body":"slideDownIn","coll_header":"slideLeftIn","sidebar":"slideUpIn"}},"path":"search.xml"};
  </script>


  <meta name="description" content="乳腺癌的分层体系是多维度的，包含组织病理学分型、临床特征和进一步的分子特征。">
<meta property="og:type" content="article">
<meta property="og:title" content="综述摘要：乳腺癌的分型策略">
<meta property="og:url" content="https://www.zhuangqingyuan.site/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/index.html">
<meta property="og:site_name" content="一个夏天的年少">
<meta property="og:description" content="乳腺癌的分层体系是多维度的，包含组织病理学分型、临床特征和进一步的分子特征。">
<meta property="og:locale" content="zh_CN">
<meta property="og:image" content="https://www.zhuangqingyuan.site/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/1.png">
<meta property="og:image" content="https://www.zhuangqingyuan.site/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/2.jpg">
<meta property="og:image" content="https://www.zhuangqingyuan.site/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/3.png">
<meta property="og:image" content="https://www.zhuangqingyuan.site/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/4.jpg">
<meta property="og:image" content="https://www.zhuangqingyuan.site/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/5.jpg">
<meta property="article:published_time" content="2024-09-21T12:46:01.000Z">
<meta property="article:modified_time" content="2024-09-21T13:08:48.212Z">
<meta property="article:author" content="Qingyuan Zhuang&#39; Blog">
<meta property="article:tag" content="肿瘤">
<meta name="twitter:card" content="summary">
<meta name="twitter:image" content="https://www.zhuangqingyuan.site/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/1.png">

<link rel="canonical" href="https://www.zhuangqingyuan.site/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/">


<script id="page-configurations">
  // https://hexo.io/docs/variables.html
  CONFIG.page = {
    sidebar: "",
    isHome : false,
    isPost : true,
    lang   : 'zh-CN'
  };
</script>

  <title>综述摘要：乳腺癌的分型策略 | 一个夏天的年少</title>
  






  <noscript>
  <style>
  .use-motion .brand,
  .use-motion .menu-item,
  .sidebar-inner,
  .use-motion .post-block,
  .use-motion .pagination,
  .use-motion .comments,
  .use-motion .post-header,
  .use-motion .post-body,
  .use-motion .collection-header { opacity: initial; }

  .use-motion .site-title,
  .use-motion .site-subtitle {
    opacity: initial;
    top: initial;
  }

  .use-motion .logo-line-before i { left: initial; }
  .use-motion .logo-line-after i { right: initial; }
  </style>
</noscript>

<link rel="alternate" href="/atom.xml" title="一个夏天的年少" type="application/atom+xml">
</head>

<body itemscope itemtype="http://schema.org/WebPage">
  <div class="container use-motion">
    <div class="headband"></div>

    <header class="header" itemscope itemtype="http://schema.org/WPHeader">
      <div class="header-inner"><div class="site-brand-container">
  <div class="site-nav-toggle">
    <div class="toggle" aria-label="切换导航栏">
      <span class="toggle-line toggle-line-first"></span>
      <span class="toggle-line toggle-line-middle"></span>
      <span class="toggle-line toggle-line-last"></span>
    </div>
  </div>

  <div class="site-meta">

    <a href="/" class="brand" rel="start">
      <span class="logo-line-before"><i></i></span>
      <h1 class="site-title">一个夏天的年少</h1>
      <span class="logo-line-after"><i></i></span>
    </a>
  </div>

  <div class="site-nav-right">
    <div class="toggle popup-trigger">
        <i class="fa fa-search fa-fw fa-lg"></i>
    </div>
  </div>
</div>




<nav class="site-nav">
  <ul id="menu" class="main-menu menu">
        <li class="menu-item menu-item-home">

    <a href="/" rel="section"><i class="fa fa-home fa-fw"></i>首页</a>

  </li>
        <li class="menu-item menu-item-about">

    <a href="/about/" rel="section"><i class="fa fa-user fa-fw"></i>关于</a>

  </li>
        <li class="menu-item menu-item-guestbook">

    <a href="/guestbook/" rel="section"><i class="fa fa-book fa-fw"></i>留言</a>

  </li>
        <li class="menu-item menu-item-stars">

    <a href="/stars/" rel="section"><i class="fa fa-star fa-fw"></i>收藏</a>

  </li>
        <li class="menu-item menu-item-friend">

    <a href="/friend/" rel="section"><i class="fa fa-link fa-fw"></i>友链</a>

  </li>
        <li class="menu-item menu-item-love">

    <a href="/love/" rel="section"><i class="fa fa-heartbeat fa-fw"></i>她</a>

  </li>
        <li class="menu-item menu-item-summer">

    <a href="/summer/" rel="section"><i class="fa fa-bullhorn fa-fw"></i>推免</a>

  </li>
      <li class="menu-item menu-item-search">
        <a role="button" class="popup-trigger"><i class="fa fa-search fa-fw"></i>搜索
        </a>
      </li>
  </ul>
</nav>



  <div class="search-pop-overlay">
    <div class="popup search-popup">
        <div class="search-header">
  <span class="search-icon">
    <i class="fa fa-search"></i>
  </span>
  <div class="search-input-container">
    <input autocomplete="off" autocapitalize="off"
           placeholder="搜索..." spellcheck="false"
           type="search" class="search-input">
  </div>
  <span class="popup-btn-close">
    <i class="fa fa-times-circle"></i>
  </span>
</div>
<div id="search-result">
  <div id="no-result">
    <i class="fa fa-spinner fa-pulse fa-5x fa-fw"></i>
  </div>
</div>

    </div>
  </div>

</div>
    </header>

    
  <a role="button" class="book-mark-link book-mark-link-fixed"></a>


    <main class="main">
      <div class="main-inner">
        <div class="content-wrap">
          

          <div class="content post posts-expand">
            

    
  
  
  <article itemscope itemtype="http://schema.org/Article" class="post-block" lang="zh-CN">
    <link itemprop="mainEntityOfPage" href="https://www.zhuangqingyuan.site/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/">

    <span hidden itemprop="author" itemscope itemtype="http://schema.org/Person">
      <meta itemprop="image" content="/images/avatar.gif">
      <meta itemprop="name" content="Qingyuan Zhuang' Blog">
      <meta itemprop="description" content="冰棒汽水的味道，一个夏天的年少。">
    </span>

    <span hidden itemprop="publisher" itemscope itemtype="http://schema.org/Organization">
      <meta itemprop="name" content="一个夏天的年少">
    </span>
      <header class="post-header">
        <h1 class="post-title" itemprop="name headline">
          综述摘要：乳腺癌的分型策略
        </h1>

        <div class="post-meta">
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-calendar"></i>
              </span>
              <span class="post-meta-item-text">发表</span>
              

              <time title="创建时间：2024-09-21 20:46:01 / 修改时间：21:08:48" itemprop="dateCreated datePublished" datetime="2024-09-21T20:46:01+08:00">2024-09-21</time>
            </span>
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-folder"></i>
              </span>
              <span class="post-meta-item-text">分类于</span>
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/%E8%82%BF%E7%98%A4%E5%AD%A6/" itemprop="url" rel="index"><span itemprop="name">肿瘤学</span></a>
                </span>
            </span>

          
            <span id="/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/" class="post-meta-item leancloud_visitors" data-flag-title="综述摘要：乳腺癌的分型策略" title="热度">
              <span class="post-meta-item-icon">
                <i class="fa fa-eye"></i>
              </span>
              <span class="post-meta-item-text">热度：</span>
              <span class="leancloud-visitors-count"></span>
            </span>
  
  <span class="post-meta-item">
    
      <span class="post-meta-item-icon">
        <i class="far fa-comment"></i>
      </span>
      <span class="post-meta-item-text">Valine：</span>
    
    <a title="valine" href="/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/#valine-comments" itemprop="discussionUrl">
      <span class="post-comments-count valine-comment-count" data-xid="/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/" itemprop="commentCount"></span>
    </a>
  </span>
  
  <br>
            <span class="post-meta-item" title="本文字数">
              <span class="post-meta-item-icon">
                <i class="far fa-file-word"></i>
              </span>
                <span class="post-meta-item-text">本文字数：</span>
              <span>5.8k</span>
            </span>
            <span class="post-meta-item" title="阅读时长">
              <span class="post-meta-item-icon">
                <i class="far fa-clock"></i>
              </span>
                <span class="post-meta-item-text">阅读时长 &asymp;</span>
              <span>21 分钟</span>
            </span>
            <div class="post-description">乳腺癌的分层体系是多维度的，包含组织病理学分型、临床特征和进一步的分子特征。</div>

        </div>
      </header>

    
    
    
    <div class="post-body" itemprop="articleBody">

      
        <!-- saved from url=(0060)https://s4.aconvert.com/convert/p3r68-cdx67/arbss-gahhf.html -->
<p><html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta http-equiv="Content-Style-Type" content="text/css"><meta name="generator" content="Aspose.Words for .NET 17.1.0.0"><title></title><style>.darkmode--activated{--body-bg-color:#282828;--content-bg-color:#333;--card-bg-color:#555;--text-color:#ccc;--blockquote-color:#bbb;--link-color:#ccc;--link-hover-color:#eee;--brand-color:#ddd;--brand-hover-color:#ddd;--table-row-odd-bg-color:#282828;--table-row-hover-bg-color:#363636;--menu-item-bg-color:#555;--btn-default-bg:#222;--btn-default-color:#ccc;--btn-default-border-color:#555;--btn-default-hover-bg:#666;--btn-default-hover-color:#ccc;--btn-default-hover-border-color:#666;--highlight-background:#282b2e;--highlight-foreground:#a9b7c6;--highlight-gutter-background:#34393d;--highlight-gutter-foreground:#9ca9b6}.darkmode--activated img{opacity:.75}.darkmode--activated img:hover{opacity:.9}.darkmode--activated code{color:#69dbdc;background:0 0}button.darkmode-toggle{z-index:9999}.darkmode-ignore,img{display:flex!important}.beian img{display:inline-block!important}</style></head><body><div><p style="margin-top:0pt; margin-bottom:0pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;; font-weight:bold">乳腺癌的分层体系是多维度的，包含组织病理学分型、临床特征和进一步的分子特征。</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="margin-left:12.97pt; text-align:justify; widows:0; orphans:0; padding-left:5.03pt; font-family:Cambria; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;">基于组织病理学的分类：</span></li></ol><p style="margin-top:0pt; margin-left:44pt; margin-bottom:0pt; text-indent:-22pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:Cambria">a)</span><span style="font:7pt &#39;Times New Roman&#39;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="font-family:&#39;楷体&#39;">原位癌（</span><span style="font-family:Cambria">carcinoma in situ</span><span style="font-family:&#39;楷体&#39;">）：</span></p><ol type="i" style="margin:0pt; padding-left:0pt"><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;">导管原位癌（</span><span>ductal carcinoma in situ, DCIS, 90%</span><span style="font-family:&#39;楷体&#39;">）：</span><ol type="1" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">导管内癌的癌前病变；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">单侧发生（</span><span>Unilateral</span><span style="font-family:&#39;楷体&#39;">）；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">仅有</span><span>10~30%</span><span style="font-family:&#39;楷体&#39;">会进展为侵袭性癌，但是没有合适的预测进展的标志物。</span></li></ol>&lt;/li&gt;</li><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;">小叶原位癌（</span><span>lobular carcinoma in situ, LCIS</span><span style="font-family:&#39;楷体&#39;">）：</span><ol type="1" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">不属于</span><span style="font-family:&#39;楷体&#39;; font-weight:bold; text-decoration:underline">癌前病变</span><span style="font-family:&#39;楷体&#39;">；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">双侧发生；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span>ER/PR</span><span style="font-family:&#39;楷体&#39;">（</span><span>+</span><span style="font-family:&#39;楷体&#39;">）；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">小叶结构完整（</span><span>lobular architecture intact</span><span style="font-family:&#39;楷体&#39;">）。</span></li>&lt;/ol&gt;&lt;/li&gt;&lt;/ol&gt;<p style="margin-top:0pt; margin-left:44pt; margin-bottom:0pt; text-indent:-22pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:Cambria">b)</span><span style="font:7pt &#39;Times New Roman&#39;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="font-family:&#39;楷体&#39;">浸润性癌（</span><span style="font-family:Cambria">invasive carcinoma</span><span style="font-family:&#39;楷体&#39;">）：</span></p><ol type="i" style="margin:0pt; padding-left:0pt"><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;">浸润性导管癌（</span><span>invasive ductal carcinoma, IDC, 60%~75%</span><span style="font-family:&#39;楷体&#39;">）：无特殊型是最常见的；</span></li><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;">浸润性小叶癌（</span><span>invasive lobular carcinoma, ILC, 10%~15%</span><span style="font-family:&#39;楷体&#39;">）：</span><span style="font-family:&#39;楷体&#39;">小叶原位癌</span><span style="font-family:&#39;楷体&#39;">根据</span><span style="font-family:&#39;楷体&#39;">组织型学特征将其进一步分为</span><span style="font-family:&#39;楷体&#39;; font-weight:bold; text-decoration:underline">经典型</span><span style="font-family:&#39;楷体&#39;; font-weight:bold; text-decoration:underline">（</span><span style="font-weight:bold; text-decoration:underline">classical</span><span style="font-family:&#39;楷体&#39;; font-weight:bold; text-decoration:underline">）</span><span style="font-family:&#39;楷体&#39;">和</span><span style="font-family:&#39;楷体&#39;; font-weight:bold; text-decoration:underline">多形型</span><span style="font-family:&#39;楷体&#39;; font-weight:bold; text-decoration:underline">（</span><span style="font-weight:bold; text-decoration:underline">pleomorphic</span><span style="font-family:&#39;楷体&#39;; font-weight:bold; text-decoration:underline">）</span><span style="font-family:&#39;楷体&#39;">。</span></li></ol><p style="margin-top:0pt; margin-left:44pt; margin-bottom:0pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;; font-weight:bold; text-decoration:underline">浸润性导管癌和浸润性小叶癌是完全不同的疾病，他们的病理学、基因组学、转移器官和治疗应答都有不同。</span></p><ol start="3" type="i" style="margin:0pt; padding-left:0pt"><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;">罕见浸润性乳腺癌（</span><span>0.1%~7%</span><span style="font-family:&#39;楷体&#39;">）：</span><ol type="1" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-left:12.97pt; padding-left:9.03pt"><span>ER</span><span style="font-family:&#39;楷体&#39;">（</span><span>+</span><span style="font-family:&#39;楷体&#39;">）：小管癌（</span><span>tubular</span><span style="font-family:&#39;楷体&#39;">）；粘液癌（</span><span>mucinous</span><span style="font-family:&#39;楷体&#39;">）；神经内分泌癌（</span><span>neuroendocrine</span><span style="font-family:&#39;楷体&#39;">）；微乳头癌（</span><span>micropapillary</span><span style="font-family:&#39;楷体&#39;">）；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span>ER</span><span style="font-family:&#39;楷体&#39;">（</span><span>-</span><span style="font-family:&#39;楷体&#39;">）：腺样囊性（</span><span>adenoid cystic</span><span style="font-family:&#39;楷体&#39;">）；化生性癌（</span><span>metaplastic</span><span style="font-family:&#39;楷体&#39;">）；髓样癌（</span><span>medullary</span><span style="font-family:&#39;楷体&#39;">）。</span></li></ol>&lt;/li&gt;&lt;/ol&gt;<p style="margin-top:0pt; margin-left:44pt; margin-bottom:0pt; text-indent:-22pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:Cambria">c)</span><span style="font:7pt &#39;Times New Roman&#39;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="font-family:Cambria">Bloom-Richardson</span><span style="font-family:&#39;楷体&#39;">三级分类系统：分化程度（生长模式和核分裂</span><span style="font-family:&#39;楷体&#39;">象</span><span style="font-family:&#39;楷体&#39;">）、增殖活力（线粒体指数）。</span></p><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><li style="margin-left:12.97pt; text-align:justify; widows:0; orphans:0; padding-left:5.03pt; font-family:Cambria; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;">临床分类：</span></li></ol><p style="margin-top:0pt; margin-left:18pt; margin-bottom:0pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;">根据</span><span style="font-family:Cambria">ER</span><span style="font-family:&#39;楷体&#39;">、</span><span style="font-family:Cambria">PR</span><span style="font-family:&#39;楷体&#39;">和</span><span style="font-family:Cambria">HER-2</span><span style="font-family:&#39;楷体&#39;">的表达，乳腺癌可以分类为：</span><span style="font-family:Cambria">ER+</span><span style="font-family:&#39;楷体&#39;">（</span><span style="font-family:Cambria">70%</span><span style="font-family:&#39;楷体&#39;">）、</span><span style="font-family:Cambria">HER-2+</span><span style="font-family:&#39;楷体&#39;">（</span><span style="font-family:Cambria">15%</span><span style="font-family:&#39;楷体&#39;">：</span><span style="font-family:Cambria">70% ER+</span><span style="font-family:&#39;楷体&#39;">，</span><span style="font-family:&#39;楷体&#39;"> </span><span style="font-family:Cambria">30%ER-</span><span style="font-family:&#39;楷体&#39;">；</span><span style="font-family:Cambria">HER-2</span><span style="font-family:&#39;楷体&#39;">低表达乳腺癌（</span><span style="font-family:Cambria">+~++</span><span style="font-family:&#39;楷体&#39;">但无</span><span style="font-family:Cambria">ERBB2</span><span style="font-family:&#39;楷体&#39;">扩增）受到越来越多的关注）和</span><span style="font-family:Cambria">TNBC</span><span style="font-family:&#39;楷体&#39;">（</span><span style="font-family:Cambria">15%</span><span style="font-family:&#39;楷体&#39;">，根据</span><span style="font-family:Cambria">EGFR</span><span style="font-family:&#39;楷体&#39;">和细胞角蛋白</span><span style="font-family:Cambria">CK5/CK14</span><span style="font-family:&#39;楷体&#39;">的表达可以进一步分型）。</span></p></li></ol></ol></li></ol></div></body></html></p>
<div style="display:flex;justify-content:center;"><img src="/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/1.png" alt="乳腺癌临床分型" style="margin:auto;"></div>
<ol start="3" type="1" style="margin:0pt; padding-left:0pt"><li style="margin-left:12.97pt; text-align:justify; widows:0; orphans:0; padding-left:5.03pt; font-family:Cambria; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;">乳腺癌的分子分型（</span><span style="font-family:&#39;楷体&#39;; font-weight:bold; text-decoration:underline">乳腺癌细胞和乳腺干细胞有惊人的相似性，提示我们分型差异源自于不同的乳腺上皮细胞在不同条件下发生的恶性转化</span><span style="font-family:&#39;楷体&#39;">）：</span></li></ol><p style="margin-top:0pt; margin-left:44pt; margin-bottom:0pt; text-indent:-22pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:Cambria">a)</span><span style="font:7pt &#39;Times New Roman&#39;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="font-family:&#39;楷体&#39;">基于</span><span style="font-family:Cambria">RNA</span><span style="font-family:&#39;楷体&#39;">微阵列数据的分型：</span><span style="font-family:Cambria">Luminal A</span><span style="font-family:&#39;楷体&#39;">、</span><span style="font-family:Cambria">Luminal B</span><span style="font-family:&#39;楷体&#39;">、</span><span style="font-family:Cambria">HER-2-enriched</span><span style="font-family:&#39;楷体&#39;">、</span><span style="font-family:Cambria">basal-like</span><span style="font-family:&#39;楷体&#39;">、</span><span style="font-family:Cambria">claudin-low</span><span style="font-family:&#39;楷体&#39;">：</span></p><ol type="i" style="margin:0pt; padding-left:0pt"><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span>Luminal A</span><span style="font-family:&#39;楷体&#39;">：</span><ol type="1" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">低级别</span><span>ER+PR+</span><span style="font-family:&#39;楷体&#39;">肿瘤；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">表达</span><span>Luminal Signature</span><span style="font-family:&#39;楷体&#39;">：</span><span>ESR1</span><span style="font-family:&#39;楷体&#39;">、</span><span>GATA3</span><span style="font-family:&#39;楷体&#39;">、</span><span>XBP1</span><span style="font-family:&#39;楷体&#39;">、</span><span>FOXA1</span><span style="font-family:&#39;楷体&#39;">；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">预后更好；</span></li></ol></li><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span>Luminal B</span><span style="font-family:&#39;楷体&#39;">：</span><ol type="1" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">高级别</span><span>ER+</span><span style="font-family:&#39;楷体&#39;">肿瘤；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">表达较低的</span><span>Luminal Signature</span><span style="font-family:&#39;楷体&#39;">，表达更高的增殖相关基因；</span></li></ol></li><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span>HER2-E</span><span style="font-family:&#39;楷体&#39;">：</span><ol type="1" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-left:12.97pt; padding-left:9.03pt"><span>ERBB2</span><span style="font-family:&#39;楷体&#39;">扩增；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">中等表达</span><span>Luminal Signature</span><span style="font-family:&#39;楷体&#39;">；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span>HER2-E</span><span style="font-family:&#39;楷体&#39;">和临床</span><span>HER2+</span><span style="font-family:&#39;楷体&#39;">分型有很大重合但不完全一致；部分</span><span>HER2-E</span><span style="font-family:&#39;楷体&#39;">患者的分子图谱和</span><span>HER2-</span><span style="font-family:&#39;楷体&#39;">肿瘤一致；</span><span>HER2+ER-</span><span style="font-family:&#39;楷体&#39;">患者中有</span><span>70%</span><span style="font-family:&#39;楷体&#39;">为</span><span>HER2-E</span><span style="font-family:&#39;楷体&#39;">；</span></li></ol></li><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span>Basal-like</span><span style="font-family:&#39;楷体&#39;">（</span><span>80% TNBC</span><span style="font-family:&#39;楷体&#39;">）：</span><ol type="1" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">表达基底角蛋白和</span><span>EGFR</span><span style="font-family:&#39;楷体&#39;">；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">低表达</span><span>Luminal Signature</span><span style="font-family:&#39;楷体&#39;">；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">高度增殖、预后较差；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">基因组不稳定，和</span><span>BRCA1</span><span style="font-family:&#39;楷体&#39;">胚系突变相关；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;; font-weight:bold; text-decoration:underline">分子图谱接近高级别浆液性卵巢癌</span><span style="font-family:&#39;楷体&#39;">；</span></li></ol></li><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span>Claudin-low</span><span style="font-family:&#39;楷体&#39;">肿瘤（一般都是</span><span>TNBC</span><span style="font-family:&#39;楷体&#39;">）：</span><ol type="1" style="margin-right:0pt; margin-left:0pt; padding-left:0pt"><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">低表达增殖特征、</span><span style="font-family:&#39;楷体&#39;">低表达粘附蛋白</span><span style="font-family:&#39;楷体&#39;">、</span><span style="font-family:&#39;楷体&#39;">低表达</span><span>Luminal Signature</span><span style="font-family:&#39;楷体&#39;">；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">有间叶组织（</span><span>mesenchymal</span><span style="font-family:&#39;楷体&#39;">）表型；</span></li><li style="margin-left:12.97pt; padding-left:9.03pt"><span style="font-family:&#39;楷体&#39;">对化疗不敏感。</span></li></ol></li></ol><p style="margin-top:0pt; margin-left:44pt; margin-bottom:0pt; text-indent:-22pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:Cambria">b)</span><span style="font:7pt &#39;Times New Roman&#39;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="font-family:Cambria">2021</span><span style="font-family:&#39;楷体&#39;">年，</span><span style="font-family:Cambria">Thennavan</span><span style="font-family:&#39;楷体&#39;">等人基于</span><span style="font-family:Cambria">TCGA</span><span style="font-family:&#39;楷体&#39;">数据库，整合多组学数据进行分型</span><span style="font-family:&#39;楷体&#39;">（</span><span style="font-family:Cambria">Thennavan</span><span style="font-family:Cambria">, et al. Cell</span><span style="font-family:Cambria"> Genomics</span><span style="font-family:Cambria">. 202</span><span style="font-family:Cambria">1</span><span style="font-family:Cambria">.</span><span style="font-family:&#39;楷体&#39;">）</span><span style="font-family:&#39;楷体&#39;">：</span></p>
<div style="display:flex;justify-content:center;"><img src="/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/2.jpg" alt="Thennavan分型" style="margin:auto;"></div>
<p style="margin-top:0pt; margin-left:44pt; margin-bottom:0pt; text-indent:-22pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:Cambria">c)</span><span style="font:7pt &#39;Times New Roman&#39;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="font-family:&#39;楷体&#39;">临床使用的芯片分型：</span></p><ol type="i" style="margin:0pt; padding-left:0pt"><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span>Oncotype DX-gene recurrence score</span><span style="font-family:&#39;楷体&#39;">（</span><span>21-gene panel</span><span style="font-family:&#39;楷体&#39;">）</span><span style="font-family:&#39;楷体&#39;">；</span></li><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span>MammaPrint</span><span style="font-family:&#39;楷体&#39;">（</span><span>70-gene panel</span><span style="font-family:&#39;楷体&#39;">）；</span></li><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span>PAM50</span><span style="font-family:&#39;楷体&#39;">（</span><span>50-gene panel</span><span style="font-family:&#39;楷体&#39;">）。</span></li></ol><ol start="4" type="1" style="margin:0pt; padding-left:0pt"><li style="margin-left:12.97pt; text-align:justify; widows:0; orphans:0; padding-left:5.03pt; font-family:Cambria; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;">乳腺癌的基因组景观（</span><span style="font-family:&#39;楷体&#39;; font-weight:bold; text-decoration:underline">乳腺癌的基因组景观是</span><span style="font-weight:bold; text-decoration:underline">C</span><span style="font-weight:bold; text-decoration:underline">NA</span><span style="font-family:&#39;楷体&#39;; font-weight:bold; text-decoration:underline">主导的</span><span style="font-family:&#39;楷体&#39;">）</span></li></ol><p style="margin-top:0pt; margin-left:44pt; margin-bottom:0pt; text-indent:-22pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:Cambria">a)</span><span style="font:7pt &#39;Times New Roman&#39;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="font-family:Cambria">Luminal A</span><span style="font-family:&#39;楷体&#39;">：</span></p><ol type="i" style="margin:0pt; padding-left:0pt"><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;">最多的复发突变基因（</span><span>recurrently mutated genes</span><span style="font-family:&#39;楷体&#39;">）：</span><span>PIK3CA</span><span style="font-family:&#39;楷体&#39;">（</span><span>~45%</span><span style="font-family:&#39;楷体&#39;">）</span></li><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;">最少的突变数目、</span><span style="font-family:&#39;楷体&#39;">最少的拷贝数变化；</span></li></ol><p style="margin-top:0pt; margin-left:44pt; margin-bottom:0pt; text-indent:-22pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:Cambria">b)</span><span style="font:7pt &#39;Times New Roman&#39;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="font-family:Cambria">Luminal B</span><span style="font-family:&#39;楷体&#39;">：</span></p><ol type="i" style="margin:0pt; padding-left:0pt"><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;">更高频率的</span><span>TP53</span><span style="font-family:&#39;楷体&#39;">突变；甲基化程度增高；</span></li><li style="margin-left:49pt; text-align:justify; widows:0; orphans:0; padding-left:17pt; font-family:Cambria; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;">特征性拷贝数变化（</span><span>copy number alterations</span><span style="font-family:&#39;楷体&#39;">）和局灶性扩增（</span><span>focal amplifications</span><span style="font-family:&#39;楷体&#39;">）；</span></li></ol><p style="margin-top:0pt; margin-left:44pt; margin-bottom:0pt; text-indent:-22pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:Cambria">c)</span><span style="font:7pt &#39;Times New Roman&#39;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="font-family:Cambria">HER2-E</span><span style="font-family:&#39;楷体&#39;">：</span><span style="font-family:&#39;楷体&#39;">高突变负担（</span><span style="font-family:Cambria">TP53</span><span style="font-family:&#39;楷体&#39;">，</span><span style="font-family:Cambria">75%</span><span style="font-family:&#39;楷体&#39;">和</span><span style="font-family:Cambria">PIK3CA</span><span style="font-family:&#39;楷体&#39;">，</span><span style="font-family:Cambria">40%</span><span style="font-family:&#39;楷体&#39;">）</span><span style="font-family:&#39;楷体&#39;">、</span><span style="font-family:Cambria">ERBB2</span><span style="font-family:&#39;楷体&#39;">扩增；</span></p><p style="margin-top:0pt; margin-left:44pt; margin-bottom:0pt; text-indent:-22pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:Cambria">d)</span><span style="font:7pt &#39;Times New Roman&#39;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="font-family:Cambria">Basal-like</span><span style="font-family:&#39;楷体&#39;">：</span><span style="font-family:&#39;楷体&#39;">复杂的</span><span style="font-family:Cambria">C</span><span style="font-family:Cambria">NA</span><span style="font-family:&#39;楷体&#39;">、重排和突变负担</span><span style="font-family:&#39;楷体&#39;">、</span><span style="font-family:Cambria">TP53</span><span style="font-family:&#39;楷体&#39;">突变（</span><span style="font-family:Cambria">80%</span><span style="font-family:&#39;楷体&#39;">）。</span></p>

<div style="display:flex;justify-content:center;"><img src="/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/3.png" alt="突变景观" style="margin:auto;"></div>

<p><ol start="5" type="1" style="margin:0pt; padding-left:0pt"><li style="margin-left:12.97pt; text-align:justify; widows:0; orphans:0; padding-left:5.03pt; font-family:Cambria; font-size:10.5pt"><span style="font-family:&#39;楷体&#39;">乳腺癌的分型策略</span></li></ol></p><p style="margin-top:0pt; margin-left:44pt; margin-bottom:0pt; text-indent:-22pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:Cambria">a)</span><span style="font:7pt &#39;Times New Roman&#39;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="font-family:Cambria; font-weight:bold">Lehmann</span><span style="font-family:&#39;楷体&#39;; font-weight:bold">分型</span><span style="font-family:&#39;楷体&#39;">：</span><span style="font-family:Cambria">2011</span><span style="font-family:&#39;楷体&#39;">年，</span><span style="font-family:Cambria">Lehmann</span><span style="font-family:&#39;楷体&#39;">等通过对</span><span style="font-family:Cambria">587</span><span style="font-family:&#39;楷体&#39;">例</span><span style="font-family:Cambria">TNBC</span><span style="font-family:&#39;楷体&#39;">的基因表达谱进行聚类分析，提出将</span><span style="font-family:Cambria">TNBC</span><span style="font-family:&#39;楷体&#39;">分为</span><span style="font-family:Cambria">6</span><span style="font-family:&#39;楷体&#39;">个分子亚型：基底样</span><span style="font-family:Cambria">-1</span><span style="font-family:&#39;楷体&#39;">型（</span><span style="font-family:Cambria">BL-1</span><span style="font-family:&#39;楷体&#39;">）、基底样</span><span style="font-family:Cambria">-2</span><span style="font-family:&#39;楷体&#39;">型（</span><span style="font-family:Cambria">BL-2</span><span style="font-family:&#39;楷体&#39;">）、免疫调节型（</span><span style="font-family:Cambria">IM</span><span style="font-family:&#39;楷体&#39;">）、间充质型（</span><span style="font-family:Cambria">M</span><span style="font-family:&#39;楷体&#39;">）、间质干细胞型（</span><span style="font-family:Cambria">MSL</span><span style="font-family:&#39;楷体&#39;">）及雄激素受体型（</span><span style="font-family:Cambria">LAR</span><span style="font-family:&#39;楷体&#39;">）。</span><span style="font-family:Cambria">2016</span><span style="font-family:&#39;楷体&#39;">年，该团队发现</span><span style="font-family:Cambria">IM</span><span style="font-family:&#39;楷体&#39;">和</span><span style="font-family:Cambria">MSL</span><span style="font-family:&#39;楷体&#39;">亚型起源于浸润的淋巴细胞和肿瘤相关基质细胞，因此将</span><span style="font-family:Cambria">TNBC</span><span style="font-family:&#39;楷体&#39;">上述</span><span style="font-family:Cambria">6</span><span style="font-family:&#39;楷体&#39;">种分子分型修正为</span><span style="font-family:Cambria">4</span><span style="font-family:&#39;楷体&#39;">种类型即</span><span style="font-family:Cambria">BL-l</span><span style="font-family:&#39;楷体&#39;">、</span><span style="font-family:Cambria">BL-2</span><span style="font-family:&#39;楷体&#39;">、</span><span style="font-family:Cambria">M</span><span style="font-family:&#39;楷体&#39;">和</span><span style="font-family:Cambria">LAR</span><span style="font-family:&#39;楷体&#39;">亚型。</span></p><p style="margin-top:0pt; margin-left:44pt; margin-bottom:0pt; text-indent:-22pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:Cambria">b)</span><span style="font:7pt &#39;Times New Roman&#39;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="font-family:Cambria; font-weight:bold">Burstein</span><span style="font-family:&#39;楷体&#39;; font-weight:bold">分型</span><span style="font-family:&#39;楷体&#39;">：</span><span style="font-family:Cambria">2015</span><span style="font-family:&#39;楷体&#39;">年，</span><span style="font-family:Cambria">Burstein</span><span style="font-family:&#39;楷体&#39;">等采用</span><span style="font-family:Cambria">WGS</span><span style="font-family:&#39;楷体&#39;">对</span><span style="font-family:Cambria">198</span><span style="font-family:&#39;楷体&#39;">例</span><span style="font-family:Cambria">TNBC</span><span style="font-family:&#39;楷体&#39;">进行了分析，将</span><span style="font-family:Cambria">TNBC</span><span style="font-family:&#39;楷体&#39;">划分为</span><span style="font-family:Cambria">4</span><span style="font-family:&#39;楷体&#39;">种亚型即</span><span style="font-family:Cambria">LAR</span><span style="font-family:&#39;楷体&#39;">、间充质型（</span><span style="font-family:Cambria">MES</span><span style="font-family:&#39;楷体&#39;">）、基底样免疫抑制型（</span><span style="font-family:Cambria">BLIS</span><span style="font-family:&#39;楷体&#39;">）和基底样免疫激活型（</span><span style="font-family:Cambria">BLIA</span><span style="font-family:&#39;楷体&#39;">）。</span><span style="font-family:Cambria">BLIA</span><span style="font-family:&#39;楷体&#39;">型</span><span style="font-family:Cambria">TNBC</span><span style="font-family:&#39;楷体&#39;">预后较好，而</span><span style="font-family:Cambria">BLIS</span><span style="font-family:&#39;楷体&#39;">型预后较差。</span></p><p style="margin-top:0pt; margin-left:44pt; margin-bottom:0pt; text-indent:-22pt; text-align:justify; widows:0; orphans:0; font-size:10.5pt"><span style="font-family:Cambria">c)</span><span style="font:7pt &#39;Times New Roman&#39;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="font-family:&#39;楷体&#39;; font-weight:bold">复旦分型</span><span style="font-family:&#39;楷体&#39;">：</span><span style="font-family:Cambria">2016</span><span style="font-family:&#39;楷体&#39;">年邵志敏课题组对中国</span><span style="font-family:Cambria">465</span><span style="font-family:&#39;楷体&#39;">例原发性</span><span style="font-family:Cambria">TNBC</span><span style="font-family:&#39;楷体&#39;">的临床资料、全基因组和</span><span style="font-family:&#39;楷体&#39;">转录组</span><span style="font-family:&#39;楷体&#39;">的测序数据进行了全面分析，该项研究更好地反映出中国</span><span style="font-family:Cambria">TNBC</span><span style="font-family:&#39;楷体&#39;">患者的基因表型特征。基于</span><span style="font-family:&#39;楷体&#39;">转录组</span><span style="font-family:&#39;楷体&#39;">测序分析数据，将中国</span><span style="font-family:Cambria">TNBC</span><span style="font-family:&#39;楷体&#39;">的分子亚型分为</span><span style="font-family:Cambria">4</span><span style="font-family:&#39;楷体&#39;">类：</span><span style="font-family:Cambria">LAR</span><span style="font-family:&#39;楷体&#39;">、</span><span style="font-family:Cambria">IM</span><span style="font-family:&#39;楷体&#39;">、</span><span style="font-family:Cambria">BLIS</span><span style="font-family:&#39;楷体&#39;">和</span><span style="font-family:Cambria">MES</span><span style="font-family:&#39;楷体&#39;">。</span><span style="font-family:Cambria">2019</span><span style="font-family:&#39;楷体&#39;">年该团队进一步验证了上述“复旦四分型”的准确性，并揭示基于分子分型的靶</span><span style="font-family:&#39;楷体&#39;">向药物</span><span style="font-family:&#39;楷体&#39;">选择是</span><span style="font-family:Cambria">TNBC</span><span style="font-family:&#39;楷体&#39;">精准治疗的重要依据。</span></p><p></p>
<div style="display:flex;justify-content:center;"><img src="/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/4.jpg" alt="现有的分型策略" style="margin:auto;"></div>
<div style="display:flex;justify-content:center;"><img src="/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/5.jpg" alt="分型的生物学基础" style="margin:auto;"></div>



    </div>

    
    
    
        

<div>
<ul class="post-copyright">
  <li class="post-copyright-author">
    <strong>本文作者： </strong>Qingyuan Zhuang' Blog
  </li>
  <li class="post-copyright-link">
    <strong>本文链接：</strong>
    <a href="https://www.zhuangqingyuan.site/2024/09/21/%E7%BB%BC%E8%BF%B0%E6%91%98%E8%A6%81%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9A%84%E5%88%86%E5%9E%8B%E7%AD%96%E7%95%A5/" title="综述摘要：乳腺癌的分型策略">https://www.zhuangqingyuan.site/2024/09/21/综述摘要：乳腺癌的分型策略/</a>
  </li>
  <li class="post-copyright-license">
    <strong>版权声明： </strong>本博客所有文章除特别声明外，均采用 <a href="https://creativecommons.org/licenses/by-nc-sa/4.0/" rel="noopener" target="_blank"><i class="fab fa-fw fa-creative-commons"></i>BY-NC-SA</a> 许可协议。转载请注明出处！
  </li>
</ul>
</div>

        

  <div class="followme">
    <p>欢迎关注我的其它发布渠道</p>

    <div class="social-list">

        <div class="social-item">
          <a target="_blank" class="social-link" href="/atom.xml">
            <span class="icon">
              <i class="fa fa-rss"></i>
            </span>

            <span class="label">RSS</span>
          </a>
        </div>
    </div>
  </div>


      <footer class="post-footer">
          
          <div class="post-tags">
              <a href="/tags/%E8%82%BF%E7%98%A4/" rel="tag"><i class="fa fa-tag"></i> 肿瘤</a>
          </div>

        
<div>
    
        <div style="text-align:center;color: #ccc;font-size:14px;">-------------　　　　本文结束　<i class="fa fa-flag"></i>　感谢阅读　　　　-------------</div>
    
</div>


        
    <div class="post-nav">
      <div class="post-nav-item">
    <a href="/2024/08/22/%E3%80%90%E8%BD%AC%E8%BD%BD%E6%96%87%E7%AB%A0%E3%80%91%E5%BD%B1%E5%83%8F%E7%BB%84%E5%AD%A6%E7%9A%84%E7%A0%94%E7%A9%B6%E6%80%9D%E8%B7%AF/" rel="prev" title="【转载文章】影像组学的研究思路">
      <i class="fa fa-chevron-left"></i> 【转载文章】影像组学的研究思路
    </a></div>
      <div class="post-nav-item">
    <a href="/2024/09/22/%E8%A1%A8%E6%A0%BC%EF%BC%9A%E4%B9%B3%E8%85%BA%E7%99%8C%E5%A4%8D%E6%97%A6%E5%88%86%E5%9E%8B/" rel="next" title="表格：乳腺癌复旦分型">
      表格：乳腺癌复旦分型 <i class="fa fa-chevron-right"></i>
    </a></div>
    </div>
      </footer>
    
    
    <div><center>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/social-share.js/1.0.16/css/share.min.css">
    <div class="social-share" data-sites="weibo, qq, qzone,wechat"></div>
    <script src="http://apps.bdimg.com/libs/jquery/1.8.2/jquery.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/social-share.js/1.0.16/js/social-share.min.js"></script>
    </center></div>  
  </article>
  
  
  



          </div>
          
    <div class="comments" id="valine-comments"></div>

<script>
  window.addEventListener('tabs:register', () => {
    let { activeClass } = CONFIG.comments;
    if (CONFIG.comments.storage) {
      activeClass = localStorage.getItem('comments_active') || activeClass;
    }
    if (activeClass) {
      let activeTab = document.querySelector(`a[href="#comment-${activeClass}"]`);
      if (activeTab) {
        activeTab.click();
      }
    }
  });
  if (CONFIG.comments.storage) {
    window.addEventListener('tabs:click', event => {
      if (!event.target.matches('.tabs-comment .tab-content .tab-pane')) return;
      let commentClass = event.target.classList[1];
      localStorage.setItem('comments_active', commentClass);
    });
  }
</script>

        </div>
          
  
  <div class="toggle sidebar-toggle">
    <span class="toggle-line toggle-line-first"></span>
    <span class="toggle-line toggle-line-middle"></span>
    <span class="toggle-line toggle-line-last"></span>
  </div>

  <aside class="sidebar">
    <div class="sidebar-inner">

      <ul class="sidebar-nav motion-element">
        <li class="sidebar-nav-toc">
          目录
        </li>
        <li class="sidebar-nav-overview">
          站点
        </li>
      </ul>

      <!--noindex-->
      <div class="post-toc-wrap sidebar-panel">
      </div>
      <!--/noindex-->

      <div class="site-overview-wrap sidebar-panel">
        <div class="site-author motion-element" itemprop="author" itemscope itemtype="http://schema.org/Person">
    <img class="site-author-image" itemprop="image" alt="Qingyuan Zhuang' Blog"
      src="/images/avatar.gif">
  <p class="site-author-name" itemprop="name">Qingyuan Zhuang' Blog</p>
  <div class="site-description" itemprop="description">冰棒汽水的味道，一个夏天的年少。</div>
</div>
<div class="site-state-wrap motion-element">
  <nav class="site-state">
      <div class="site-state-item site-state-posts">
          <a href="/archives">
          <span class="site-state-item-count">50</span>
          <span class="site-state-item-name">日志</span>
        </a>
      </div>
      <div class="site-state-item site-state-categories">
            <a href="/categories/">
        <span class="site-state-item-count">8</span>
        <span class="site-state-item-name">分类</span></a>
      </div>
      <div class="site-state-item site-state-tags">
            <a href="/tags/">
        <span class="site-state-item-count">30</span>
        <span class="site-state-item-name">标签</span></a>
      </div>
  </nav>
</div>
  <div class="links-of-author motion-element">
      <span class="links-of-author-item">
        <a href="https://github.com/ForrestGump618" title="GitHub → https:&#x2F;&#x2F;github.com&#x2F;ForrestGump618" rel="noopener" target="_blank"><i class="fab fa-github fa-fw"></i>GitHub</a>
      </span>
      <span class="links-of-author-item">
        <a href="mailto:zhuangqingyuan@foxmail.com" title="E-Mail → mailto:zhuangqingyuan@foxmail.com" rel="noopener" target="_blank"><i class="fa fa-envelope fa-fw"></i>E-Mail</a>
      </span>
      <span class="links-of-author-item">
        <a href="https://weibo.com/u/7564625671" title="Weibo → https:&#x2F;&#x2F;weibo.com&#x2F;u&#x2F;7564625671" rel="noopener" target="_blank"><i class="fab fa-weibo fa-fw"></i>Weibo</a>
      </span>
      <span class="links-of-author-item">
        <a href="https://twitter.com/Xiao200105" title="Twitter → https:&#x2F;&#x2F;twitter.com&#x2F;Xiao200105" rel="noopener" target="_blank"><i class="fab fa-twitter fa-fw"></i>Twitter</a>
      </span>
      <span class="links-of-author-item">
        <a href="https://www.zhihu.com/people/zhuang-qing-yuan-18" title="ZhiHu → https:&#x2F;&#x2F;www.zhihu.com&#x2F;people&#x2F;zhuang-qing-yuan-18" rel="noopener" target="_blank"><i class="fab fa-zhihu fa-fw"></i>ZhiHu</a>
      </span>
      <span class="links-of-author-item">
        <a href="https://orcid.org/0000-0002-0333-8192" title="ORCID → https:&#x2F;&#x2F;orcid.org&#x2F;0000-0002-0333-8192" rel="noopener" target="_blank"><i class="fab fa-orcid fa-fw"></i>ORCID</a>
      </span>
  </div>



      </div>
        <div class="back-to-top motion-element">
          <i class="fa fa-arrow-up"></i>
          <span>0%</span>
        </div>

      
        <script type="text/javascript" charset="utf-8" src="/js/tagcloud.js"></script>
        <script type="text/javascript" charset="utf-8" src="/js/tagcanvas.js"></script>
        <div class="widget-wrap">
          <!--<h3 class="widget-title">Tag Cloud</h3>
          -->
          <div id="myCanvasContainer" class="widget tagcloud">
          <canvas width="250" height="250" id="resCanvas" style="width=100%">
            <ul class="tag-list" itemprop="keywords"><li class="tag-list-item"><a class="tag-list-link" href="/tags/AI/" rel="tag">AI</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/Docker/" rel="tag">Docker</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/GWAS/" rel="tag">GWAS</a><span class="tag-list-count">4</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/HEXO/" rel="tag">HEXO</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/LLM/" rel="tag">LLM</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/python/" rel="tag">python</a><span class="tag-list-count">2</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E4%BA%A4%E5%8F%89%E5%AD%A6%E7%A7%91/" rel="tag">交叉学科</a><span class="tag-list-count">2</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E5%85%8D%E7%96%AB/" rel="tag">免疫</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E5%8C%BB%E5%AD%A6/" rel="tag">医学</a><span class="tag-list-count">8</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E5%8C%BB%E5%AD%A6%E7%94%9F/" rel="tag">医学生</a><span class="tag-list-count">8</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E5%8D%95%E7%BB%86%E8%83%9E%E6%B5%8B%E5%BA%8F/" rel="tag">单细胞测序</a><span class="tag-list-count">9</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E5%A4%A7%E5%9B%9B/" rel="tag">大四</a><span class="tag-list-count">7</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E5%AD%9F%E5%BE%B7%E5%B0%94%E9%9A%8F%E6%9C%BA%E5%8C%96/" rel="tag">孟德尔随机化</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E5%AF%86%E7%A0%81%E5%AD%A6/" rel="tag">密码学</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E5%BC%80%E6%BA%90/" rel="tag">开源</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E5%BD%B1%E5%83%8F%E7%BB%84%E5%AD%A6/" rel="tag">影像组学</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E5%BF%83%E5%86%85%E7%A7%91/" rel="tag">心内科</a><span class="tag-list-count">2</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E6%99%BA%E8%83%BD%E9%9F%B3%E7%AE%B1/" rel="tag">智能音箱</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E6%9C%BA%E5%99%A8%E5%AD%A6%E4%B9%A0/" rel="tag">机器学习</a><span class="tag-list-count">12</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E6%B5%81%E8%A1%8C%E7%97%85%E5%AD%A6/" rel="tag">流行病学</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E6%B7%B1%E5%BA%A6%E5%AD%A6%E4%B9%A0/" rel="tag">深度学习</a><span class="tag-list-count">9</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E7%88%AC%E8%99%AB/" rel="tag">爬虫</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E7%94%9F%E7%89%A9%E4%BF%A1%E6%81%AF%E5%AD%A6/" rel="tag">生物信息学</a><span class="tag-list-count">11</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E7%A0%94%E7%A9%B6%E7%94%9F/" rel="tag">研究生</a><span class="tag-list-count">2</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E7%BB%9F%E8%AE%A1%E5%AD%A6/" rel="tag">统计学</a><span class="tag-list-count">8</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E8%82%BF%E7%98%A4/" rel="tag">肿瘤</a><span class="tag-list-count">6</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E8%AE%A1%E6%95%B0/" rel="tag">计数</a><span class="tag-list-count">1</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E8%AE%A1%E7%AE%97%E6%9C%BA/" rel="tag">计算机</a><span class="tag-list-count">3</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E8%BD%AC%E5%BD%95%E7%BB%84%E5%AD%A6/" rel="tag">转录组学</a><span class="tag-list-count">6</span></li><li class="tag-list-item"><a class="tag-list-link" href="/tags/%E9%9A%8F%E7%AC%94/" rel="tag">随笔</a><span class="tag-list-count">5</span></li></ul>
          </canvas>
          </div>
        </div>
      

    </div>
  </aside>
  <div id="sidebar-dimmer"></div>


      </div>
    </main>

    <footer class="footer">
      <div class="footer-inner">
        

        

<div style="text-align:center;" class="copyright">
  
  &copy; 2023 – 
  <span itemprop="copyrightYear">2024</span>
  <span class="with-love">
    <i class="fa fa-heart"></i>
  </span>
  <span class="author" itemprop="copyrightHolder">Qingyuan Zhuang</span>
</div>

<div style="text-align:center;" class="copyright">
    <span class="post-meta-item-icon">
      <i class="fa fa-chart-area"></i>
    </span>
    <span title="站点总字数">228k</span>

    <span class="post-meta-item-icon">
      <span class="post-meta-divider"> </span>
      <i class="fa fa-coffee"></i>
    </span>
    <span title="站点阅读时长">13:49</span>
  
  
    <script async src="//dn-lbstatics.qbox.me/busuanzi/2.3/busuanzi.pure.mini.js"></script>
    <span class="post-meta-divider"> </span>
    <span class="post-meta-item-icon">
      <i class="fa fa-eye"></i>
    </span>
    <span id="busuanzi_container_site_pv"><span id="busuanzi_value_site_pv"></span>次</span>
    <span class="post-meta-divider"> </span>
    <span class="post-meta-item-icon">
      <i class="fa fa-fire"></i>
    </span>
    <span id="busuanzi_container_site_uv"><span id="busuanzi_value_site_uv"></span>人</span>
</div>




<script>
$(document).ready(function() {

    var int = setInterval(fixCount, 50);  // 50ms周期检测函数
    var countOffset = 20000;  // 初始化首次数据

    function fixCount() {            
       if (document.getElementById("busuanzi_container_site_pv").style.display != "none")
        {
            $("#busuanzi_value_site_pv").html(parseInt($("#busuanzi_value_site_pv").html()) + countOffset); 
            clearInterval(int);
        }                  
        if ($("#busuanzi_container_site_pv").css("display") != "none")
        {
            $("#busuanzi_value_site_uv").html(parseInt($("#busuanzi_value_site_uv").html()) + countOffset); // 加上初始数据 
            clearInterval(int); // 停止检测
        }  
    }
});
</script> 

<div style="text-align:center;">
<!--添加网站运行时间-->
<span>小破站已经在风雨中度过了</span>
<span id="timeDate">载入天数...</span>
<span id="times">载入时分秒...</span>
<script>
    function createtime() {
        const startTime = '08/11/2023 20:00:00',
            start = new Date(startTime)
        let mill = new Date() - start,
            seconds = Math.floor(mill / 1000),
            mins = Math.floor(seconds / 60),
            hours = Math.floor(mins / 60),
            days = Math.floor(hours / 24)
        const time = {
            seconds: seconds - mins * 60,
            mins: mins - hours * 60,
            hours: hours - days * 24,
        }
        for (const k in time) {
            time[k] = `${time[k]}`.padStart(2, '0')
        }
        document.getElementById("timeDate").innerHTML = ` ${days} 天`
        document.getElementById("times").innerHTML = ` ${time.hours} 小时 ${time.mins} 分 ${time.seconds} 秒`
    }
    setInterval(createtime, 500)
</script>
</div>



        
<div class="busuanzi-count">
  <script data-pjax async src="https://busuanzi.ibruce.info/busuanzi/2.3/busuanzi.pure.mini.js"></script>
    <span class="post-meta-item" id="busuanzi_container_site_uv" style="display: none;">
      <span class="post-meta-item-icon">
        <i class="fa fa-user"></i>
      </span>
      <span class="site-uv" title="总访客量">
        <span id="busuanzi_value_site_uv"></span>
      </span>
    </span>
    <span class="post-meta-item" id="busuanzi_container_site_pv" style="display: none;">
      <span class="post-meta-item-icon">
        <i class="fa fa-eye"></i>
      </span>
      <span class="site-pv" title="总访问量">
        <span id="busuanzi_value_site_pv"></span>
      </span>
    </span>
</div>








      </div>
    </footer>
  </div>

  
  <script src="//cdn.jsdelivr.net/npm/animejs@3.2.2/lib/anime.min.js"></script>
  <script src="//cdn.jsdelivr.net/gh/theme-next/theme-next-pjax@0/pjax.min.js"></script>
  <script src="//cdn.jsdelivr.net/npm/jquery@3/dist/jquery.min.js"></script>
  <script src="//cdn.jsdelivr.net/gh/fancyapps/fancybox@3/dist/jquery.fancybox.min.js"></script>
  <script src="//cdn.jsdelivr.net/npm/velocity-animate@1.5.2/velocity.min.js"></script>
  <script src="/lib/velocity/velocity.ui.min.js"></script>

<script src="/js/utils.js"></script>

<script src="/js/motion.js"></script>


<script src="/js/schemes/muse.js"></script>


<script src="/js/next-boot.js"></script>

<script src="/js/bookmark.js"></script>

  <script>
var pjax = new Pjax({
  selectors: [
    'head title',
    '#page-configurations',
    '.content-wrap',
    '.post-toc-wrap',
    '.languages',
    '#pjax'
  ],
  switches: {
    '.post-toc-wrap': Pjax.switches.innerHTML
  },
  analytics: false,
  cacheBust: false,
  scrollTo : !CONFIG.bookmark.enable
});

window.addEventListener('pjax:success', () => {
  document.querySelectorAll('script[data-pjax], script#page-configurations, #pjax script').forEach(element => {
    var code = element.text || element.textContent || element.innerHTML || '';
    var parent = element.parentNode;
    parent.removeChild(element);
    var script = document.createElement('script');
    if (element.id) {
      script.id = element.id;
    }
    if (element.className) {
      script.className = element.className;
    }
    if (element.type) {
      script.type = element.type;
    }
    if (element.src) {
      script.src = element.src;
      // Force synchronous loading of peripheral JS.
      script.async = false;
    }
    if (element.dataset.pjax !== undefined) {
      script.dataset.pjax = '';
    }
    if (code !== '') {
      script.appendChild(document.createTextNode(code));
    }
    parent.appendChild(script);
  });
  NexT.boot.refresh();
  // Define Motion Sequence & Bootstrap Motion.
  if (CONFIG.motion.enable) {
    NexT.motion.integrator
      .init()
      .add(NexT.motion.middleWares.subMenu)
      .add(NexT.motion.middleWares.postList)
      .bootstrap();
  }
  NexT.utils.updateSidebarPosition();
});
</script>




  
  <script data-pjax>
    (function(){
      var canonicalURL, curProtocol;
      //Get the <link> tag
      var x=document.getElementsByTagName("link");
		//Find the last canonical URL
		if(x.length > 0){
			for (i=0;i<x.length;i++){
				if(x[i].rel.toLowerCase() == 'canonical' && x[i].href){
					canonicalURL=x[i].href;
				}
			}
		}
    //Get protocol
	    if (!canonicalURL){
	    	curProtocol = window.location.protocol.split(':')[0];
	    }
	    else{
	    	curProtocol = canonicalURL.split(':')[0];
	    }
      //Get current URL if the canonical URL does not exist
	    if (!canonicalURL) canonicalURL = window.location.href;
	    //Assign script content. Replace current URL with the canonical URL
      !function(){var e=/([http|https]:\/\/[a-zA-Z0-9\_\.]+\.baidu\.com)/gi,r=canonicalURL,t=document.referrer;if(!e.test(r)){var n=(String(curProtocol).toLowerCase() === 'https')?"https://sp0.baidu.com/9_Q4simg2RQJ8t7jm9iCKT-xh_/s.gif":"//api.share.baidu.com/s.gif";t?(n+="?r="+encodeURIComponent(document.referrer),r&&(n+="&l="+r)):r&&(n+="?l="+r);var i=new Image;i.src=n}}(window);})();
  </script>




  
<script src="/js/local-search.js"></script>






  <script src="//code.tidio.co/qqrjcchnt9lv02g8xd8s3ouwpqtxtia2.js"></script>







    <div id="pjax">
  

  

  
<script src="https://cdn.jsdelivr.net/npm/darkmode-js@1.5.7/lib/darkmode-js.min.js"></script>

<script>
var options = {
  bottom: '128px',
  right: 'unset',
  left: '32px',
  time: '0.s',
  mixColor: 'transparent',
  backgroundColor: 'transparent',
  buttonColorDark: '#100f2c',
  buttonColorLight: '#fff',
  saveInCookies: true,
  label: '🌓',
  autoMatchOsTheme: true
}
const darkmode = new Darkmode(options);
window.darkmode = darkmode;
darkmode.showWidget();
</script>


<script>
NexT.utils.loadComments(document.querySelector('#valine-comments'), () => {
  NexT.utils.getScript('//unpkg.com/valine@latest/dist/Valine.min.js', () => {
    var GUEST = ['nick', 'mail', 'link'];
    var guest = 'nick,mail,link';
    guest = guest.split(',').filter(item => {
      return GUEST.includes(item);
    });
    new Valine({
      el         : '#valine-comments',
      verify     : false,
      notify     : false,
      appId      : 'Dn2HgqGikthxTy5tlhKqdRK8-gzGzoHsz',
      appKey     : 'B9a4a4bFtqIKoDkPg7p2em3j',
      placeholder: "Just go go",
      avatar     : 'mm',
      meta       : guest,
      pageSize   : '10' || 10,
      visitor    : true,
      lang       : '' || 'zh-cn',
      path       : location.pathname,
      recordIP   : true,
      serverURLs : 'https://dn2hgqgi.lc-cn-n1-shared.com'
    });
  }, window.Valine);
});
</script>

    </div>
</body>
</html>

<!-- 页面点击小红心 -->
<script type="text/javascript" src="/js/love.js"></script>